Developing andmanufacturing breakthrough pharmaceuticals for a global market is always a challenge. At Recipharm, we’ve developed world-class solutions that meet the demands of the most complex assignments.
For RedHill Biopharma Ltd. in Israel, we’ve signed an agreement to supply the remaining clinical trial material and future commercial supply for RHB-105 – developed for the treatment of Helicobacter pylori (H. pylori) bacterial infection.
For the project, Recipharm integrating three of our locations, two in Fontaine and Pessac, France together with our facility in Strangnäs, Sweden, to manufacture and package RHB-105 for markets in a variety of countries around the world.
Click here to get more details of the RedHill agreement to learn how Recipharm puts solutions in place to meet demanding challenges for our customers. Like you.